+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The protective role of transient receptor potential vanilloid subtype 1 in post-myocardial infarction inflammation process.



The protective role of transient receptor potential vanilloid subtype 1 in post-myocardial infarction inflammation process.



Zhonghua Xin Xue Guan Bing Za Zhi 37(3): 227-232



To investigate the protective role of transient receptor potential vanilloid subtype 1 (TRPV1) in inflammatory process after myocardial infarction. The survival rate, infarct size, the levels of plasma cardiac troponin I, infiltration of inflammatory cells, the levels of cytokines and chemokines, and cardiac function were monitored 3 and 7 days post-myocardial infarction in TRPV1 gene knockout (TRPV1(-/-)) and wild type (WT) mice. The survival rate was significantly lower in TRPV1(-/-) mice than that in WT mice (62.5% vs. 82.1%, P < 0.05). The infarct size on day 3 after MI was significantly larger in TRPV1(-/-) mice than that in WT mice (INF/AAR: 69.5% +/- 3.1% vs. 40.1% +/- 2.6%, P < 0.05). Plasma cardiac troponin I level, number of infiltrated inflammatory cells including neutrophils and macrophages were significant increased in TRPV1(-/-) mice compared to WT mice. Expressions of cytokines including TNF-alpha, IL-1beta, and IL-6, chemokines including MCP-1 and MIP-2 in the infarct area at 3 and 7 days after MI were significantly higher in TRPV1(-/-) mice than those in WT mice (all P < 0.05). Furthermore, end-systolic and -diastolic diameters were significantly increased and contractile function of the heart significantly reduced in TRPV1(-/-) mice compared to WT mice. TRPV1 gene deletion results in reduced survival rate, excessive inflammation, deteriorated cardiac function and aggravated left ventricular remodelling after MI, indicating that TRPV1 may prevent infarct expansion and cardiac injury by inhibiting inflammation and reservation cardiac function.

(PDF emailed within 1 workday: $29.90)

Accession: 056449358

Download citation: RISBibTeXText

PMID: 19781146


Related references

Transient Receptor Potential Vanilloid Subtype 1 Inhibits Inflammation and Apoptosis via the Release of Calcitonin Gene-Related Peptide in the Heart after Myocardial Infarction. Cardiology 134(4): 436-443, 2016

Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. Hypertension 53(2): 243-250, 2009

Propofol restores transient receptor potential vanilloid receptor subtype-1 sensitivity via activation of transient receptor potential ankyrin receptor subtype-1 in sensory neurons. Anesthesiology 114(5): 1169-1179, 2011

Transgenic overexpression of transient receptor potential vanilloid subtype 1 attenuates isoproterenol-induced myocardial fibrosis in mice. International Journal of Molecular Medicine 38(2): 601-609, 2016

Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. Journal of Neuroscience 25(39): 8924-8937, 2005

Role of transient receptor potential vanilloid 4 in rat joint inflammation. Arthritis and Rheumatism 64(6): 1848-1858, 2012

Role of the transient receptor potential vanilloid 1 in inflammation and sepsis. Journal of Inflammation Research 4: 67-81, 2011

Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease. Brain Research 1642: 397-408, 2017

Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 193: 440-451, 2012

The transient receptor potential vanilloid 1: role in airway inflammation and disease. European Journal of Pharmacology 533(1-3): 207-214, 2006

Role of transient receptor potential vanilloid 1 in inflammation and autoimmune diseases. Pharmaceuticals 5(8): 837-852, 2012

The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacology & Therapeutics 125(2): 181-195, 2010

A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. British Journal of Pharmacology 159(5): 1161-1173, 2010

Role of transient receptor potential vanilloid 1 in airway inflammation in asthmatic mice. Zhongguo Dang Dai Er Ke Za Zhi 18(9): 874-878, 2016

Transient receptor potential vanilloid 1 - a polymodal nociceptive receptor - plays a crucial role in formaldehyde-induced skin inflammation in mice. Journal of Pharmacological Sciences 118(2): 266-274, 2012